Business question from Peter Viggers (Conservative) in the House of Commons on Thursday, 6 December 2007. It occurred during Business statement on Business of the House.
Business of the House
Will the Leader of the House find time at an early date for a debate on an issue that those directly concerned find the most important of all, namely the availability of the drug Alimta for the treatment of mesothelioma? Is the Leader of the House aware that the drug has been approved by the National Institute for Health and Clinical Excellence and is available through some primary care trusts, but not through others who have taken legal action to prevent the requirement that they should use it? Does she agree that the debate might allow opinion from both sides of the House to bring pressure to bear so that the intolerable situation can be drawn to a conclusion?
Secondary information
- Type
- Proceeding contribution
- Reference
- 468 c972
- Session
- 2007-08
- Chamber / Committee
- House of Commons chamber
- Subjects
- Drugs NHS Mesothelioma
- Link
- View this Proceeding contribution on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2023-12-16 02:22:33 +0000
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1281713/-question
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1281713/-question
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1281713/-question